Calliditas Therapeutics AB
STO:CALTX

Watchlist Manager
Calliditas Therapeutics AB Logo
Calliditas Therapeutics AB
STO:CALTX
Watchlist
Price: 208 SEK 0.87%
Market Cap: 12.5B SEK
Have any thoughts about
Calliditas Therapeutics AB?
Write Note

Relative Value

The Relative Value of one CALTX stock under the Base Case scenario is 435.89 SEK. Compared to the current market price of 208 SEK, Calliditas Therapeutics AB is Undervalued by 52%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CALTX Relative Value
Base Case
435.89 SEK
Undervaluation 52%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
61
vs Industry
17
Median 3Y
7.8
Median 5Y
18.1
Industry
2.5
Forward
6.2
vs History
vs Industry
Median 3Y
-13.4
Median 5Y
-15.1
Industry
21.9
Forward
88.8
vs History
vs Industry
Median 3Y
-17
Median 5Y
-19.5
Industry
16.5
vs History
vs Industry
Median 3Y
-21.6
Median 5Y
-23.9
Industry
23.6
vs History
0
vs Industry
0
Median 3Y
10.3
Median 5Y
7.6
Industry
2.1
vs History
58
vs Industry
15
Median 3Y
7.9
Median 5Y
15.9
Industry
2.6
Forward
6.3
vs History
15
vs Industry
22
Median 3Y
7.9
Median 5Y
5.1
Industry
5.2
vs History
vs Industry
Median 3Y
-14.2
Median 5Y
-17.7
Industry
13.3
Forward
64.7
vs History
vs Industry
Median 3Y
-14.2
Median 5Y
-17.1
Industry
16.6
Forward
70.6
vs History
vs Industry
Median 3Y
-17
Median 5Y
-18.7
Industry
15.6
vs History
vs Industry
Median 3Y
-17
Median 5Y
-18.7
Industry
19.1
vs History
22
vs Industry
8
Median 3Y
9.7
Median 5Y
10.9
Industry
1.9

Multiples Across Competitors

CALTX Competitors Multiples
Calliditas Therapeutics AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Calliditas Therapeutics AB
STO:CALTX
12.5B SEK 7.8 -26 -35.9 -35.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.7B USD 18.3 89.6 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.2 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
372B USD 4.2 25.3 12.2 15.9
US
Merck & Co Inc
NYSE:MRK
257.3B USD 4.1 21.2 10.7 12.8
CH
Roche Holding AG
SIX:ROG
201.7B CHF 3.4 17.5 9.9 11.7
UK
AstraZeneca PLC
LSE:AZN
163B GBP 4.2 31.8 169.5 254
CH
Novartis AG
SIX:NOVN
179.6B CHF 4.1 11.5 9.9 13.9
US
Pfizer Inc
NYSE:PFE
146B USD 2.4 34.3 10.3 15.6
P/E Multiple
Earnings Growth
SE
Calliditas Therapeutics AB
STO:CALTX
Average P/E: 33.3
Negative Multiple: -26
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.6
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.3
-22%
US
Merck & Co Inc
NYSE:MRK
21.2
7 321%
CH
Roche Holding AG
SIX:ROG
17.5
32%
UK
AstraZeneca PLC
LSE:AZN
31.8
177%
CH
Novartis AG
SIX:NOVN
11.5
21%
US
Pfizer Inc
NYSE:PFE
34.3
733%

See Also

Discover More
Back to Top